T1D Fund
Boston, Massachusettst1dfund.org
Overview
The T1D Fund is a venture philanthropy fund accelerating life-changing solutions to treat, prevent, and ultimately cure T1D . Launched in December 2016, its aim is to attract and deploy capital to advance promising disease-modifying therapies and provide cures for those living with T1D .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Zag Bio | Oct 2025 | Series A | Lead |
| Kriya Therapeutics | Sep 2025 | Series D | Co-investor |
| Zucara Therapeutics Inc. | May 2025 | Series B | Co-investor |
| Aspect Biosystems | Jan 2025 | Series B | Co-investor |
| Cour Pharma | Jan 2024 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
